Clinical trial
A Prospective, Multicenter, Single-Blind, Randomized Controlled Clinical Trial of an Autologous Platelet-Rich Concentrated Growth Factor (CGF) Preparation Kit for the Treatment of Knee Osteoarthritis
NCT06869200 is registered in ClinicalTrials.gov with Guangdong Hongzhi Health Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single-Blind, Randomized Controlled Clinical Trial of an Autologous Platelet-Rich Concentrated Growth Factor (CGF) Preparation Kit for the Treatment of Knee Osteoarthritis
- Lead sponsor
- Guangdong Hongzhi Health Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 13, 2025
- Completion date
- September 17, 2025
- Enrollment
- 104 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis